{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T07:41:46Z","timestamp":1791013306479,"version":"4.1.0"},"reference-count":23,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2008,5,1]],"date-time":"2008-05-01T00:00:00Z","timestamp":1209600000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biochemical and Biophysical Research Communications"],"published-print":{"date-parts":[[2008,5]]},"DOI":"10.1016\/j.bbrc.2008.02.125","type":"journal-article","created":{"date-parts":[[2008,3,7]],"date-time":"2008-03-07T19:03:22Z","timestamp":1204916602000},"page":"1071-1075","source":"Crossref","is-referenced-by-count":57,"title":["Isofagomine increases lysosomal delivery of exogenous glucocerebrosidase"],"prefix":"10.1016","volume":"369","author":[{"given":"Jin-Song","family":"Shen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nancy J.","family":"Edwards","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Young Bin","family":"Hong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gary J.","family":"Murray","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbrc.2008.02.125_bib1","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/0006-291X(65)90743-6","article-title":"Metabolism of glucocerebrosides. Ii. Evidence of an enzymatic deficiency in Gaucher\u2019s disease","volume":"18","author":"Brady","year":"1965","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.bbrc.2008.02.125_bib2","series-title":"The Metabolic and Molecular Bases of Inherited Diseases","first-page":"3635","article-title":"Gaucher disease","author":"Beutler","year":"2001"},{"key":"10.1016\/j.bbrc.2008.02.125_bib3","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1146\/annurev.med.57.110104.115650","article-title":"Enzyme replacement for lysosomal diseases","volume":"57","author":"Brady","year":"2006","journal-title":"Annu. Rev. Med."},{"key":"10.1016\/j.bbrc.2008.02.125_bib4","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/S0002-9343(02)01150-6","article-title":"Effectiveness of enzyme replacement therapy in 1028 patients with type 1 Gaucher disease after 2 to 5 years of treatment: a report from the Gaucher registry","volume":"113","author":"Weinreb","year":"2002","journal-title":"Am. J. Med."},{"key":"10.1016\/j.bbrc.2008.02.125_bib5","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1023\/B:BOLI.0000031101.12838.c6","article-title":"Enzyme replacement and enhancement therapies for lysosomal diseases","volume":"27","author":"Desnick","year":"2004","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.bbrc.2008.02.125_bib6","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1177\/43.2.7822772","article-title":"Immunoelectron microscopic localization of mannose-terminal glucocerebrosidase in lysosomes of rat liver Kupffer cells","volume":"43","author":"Murray","year":"1995","journal-title":"J. Histochem. Cytochem."},{"key":"10.1016\/j.bbrc.2008.02.125_bib7","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1203\/00006450-199602000-00021","article-title":"Turnover and distribution of intravenously administered mannose-terminated human acid beta-glucosidase in murine and human tissues","volume":"39","author":"Xu","year":"1996","journal-title":"Pediatr. Res."},{"key":"10.1016\/j.bbrc.2008.02.125_bib8","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1023\/A:1022578424693","article-title":"Delivery, distribution, and neuronal uptake of exogenous mannose-terminal glucocerebrosidase in the intact rat brain","volume":"24","author":"Zirzow","year":"1999","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.bbrc.2008.02.125_bib9","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1517\/17425247.3.6.771","article-title":"Delivery of lysosomal enzymes for therapeutic use: glucocerebrosidase as an example","volume":"3","author":"Grabowski","year":"2006","journal-title":"Expert Opin. Drug Deliv."},{"key":"10.1016\/j.bbrc.2008.02.125_bib10","doi-asserted-by":"crossref","first-page":"3862","DOI":"10.1016\/S0021-9258(19)85604-1","article-title":"Substrate stabilization of lysozyme to thermal and guanidine hydrochloride denaturation","volume":"255","author":"Pace","year":"1980","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbrc.2008.02.125_bib11","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/0076-6879(95)49034-5","article-title":"Kinetics of slow and tight-binding inhibitors","volume":"249","author":"Szedlacsek","year":"1995","journal-title":"Methods Enzymol."},{"key":"10.1016\/j.bbrc.2008.02.125_bib12","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/0167-4838(90)90220-A","article-title":"Human acid beta-glucosidase: use of sphingosyl and N-alkyl-glucosylamine inhibitors to investigate the properties of the active site","volume":"1039","author":"Greenberg","year":"1990","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.bbrc.2008.02.125_bib13","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1042\/bj3490211","article-title":"Investigation of the slow inhibition of almond beta-glucosidase and yeast isomaltase by 1-azasugar inhibitors: evidence for the \u2018direct binding\u2019 model","volume":"349","author":"Lohse","year":"2000","journal-title":"Biochem. J."},{"key":"10.1016\/j.bbrc.2008.02.125_bib14","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1016\/0076-6879(78)50049-9","article-title":"Enzymic diagnosis of sphingolipidoses","volume":"50","author":"Suzuki","year":"1978","journal-title":"Methods Enzymol."},{"key":"10.1016\/j.bbrc.2008.02.125_bib15","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1002\/jlb.42.5.485","article-title":"Generation of macrophage variants with 5-azacytidine: selection for mannose receptor expression","volume":"42","author":"Diment","year":"1987","journal-title":"J. Leukoc. Biol."},{"key":"10.1016\/j.bbrc.2008.02.125_bib16","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/0003-2697(85)90442-7","article-title":"Measurement of protein using bicinchoninic acid","volume":"150","author":"Smith","year":"1985","journal-title":"Anal. Biochem."},{"key":"10.1016\/j.bbrc.2008.02.125_bib17","doi-asserted-by":"crossref","first-page":"4350","DOI":"10.1073\/pnas.76.9.4350","article-title":"Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications","volume":"76","author":"Towbin","year":"1979","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.bbrc.2008.02.125_bib18","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1016\/0006-291X(76)90760-9","article-title":"Solubilization of glucocerebrosidase from human placenta and demonstration of a phospholipid requirement for its catalytic activity","volume":"71","author":"Dale","year":"1976","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.bbrc.2008.02.125_bib19","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1038\/nchembio850","article-title":"Structure of acid beta-glucosidase with pharmacological chaperone provides insight into Gaucher disease","volume":"3","author":"Lieberman","year":"2007","journal-title":"Nat. Chem. Biol."},{"key":"10.1016\/j.bbrc.2008.02.125_bib20","doi-asserted-by":"crossref","first-page":"15428","DOI":"10.1073\/pnas.192582899","article-title":"Chemical chaperones increase the cellular activity of N370S beta-glucosidase: a therapeutic strategy for Gaucher disease","volume":"99","author":"Sawkar","year":"2002","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.bbrc.2008.02.125_bib21","doi-asserted-by":"crossref","first-page":"13813","DOI":"10.1073\/pnas.0605928103","article-title":"The iminosugar isofagomine increases the activity of N370S mutant acid beta-glucosidase in Gaucher fibroblasts by several mechanisms","volume":"103","author":"Steet","year":"2006","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.bbrc.2008.02.125_bib22","doi-asserted-by":"crossref","first-page":"4082","DOI":"10.1111\/j.1742-4658.2006.05410.x","article-title":"Hydrophilic iminosugar active-site-specific chaperones increase residual glucocerebrosidase activity in fibroblasts from Gaucher patients","volume":"273","author":"Chang","year":"2006","journal-title":"FEBS J."},{"key":"10.1016\/j.bbrc.2008.02.125_bib23","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1517\/13543784.10.3.455","article-title":"Substrate reduction therapy for glycosphingolipid storage disorders","volume":"10","author":"Lachmann","year":"2001","journal-title":"Expert Opin. Investig. Drugs"}],"container-title":["Biochemical and Biophysical Research Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X08004348?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X08004348?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,9,5]],"date-time":"2021-09-05T13:40:31Z","timestamp":1630849231000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006291X08004348"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,5]]},"references-count":23,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2008,5]]}},"alternative-id":["S0006291X08004348"],"URL":"https:\/\/doi.org\/10.1016\/j.bbrc.2008.02.125","relation":{},"ISSN":["0006-291X"],"issn-type":[{"value":"0006-291X","type":"print"}],"subject":[],"published":{"date-parts":[[2008,5]]}}}